| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,268,249 |
|
|
|
Indirect Value
|
$149,961,660 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$151,229,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-06 |
4 |
D |
$79.92 |
$4,378,817 |
D/D |
(54,790) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-08-17 |
4 |
S |
$42.10 |
$4,634,100 |
D/D |
(110,000) |
491,573 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-10-25 |
4 |
S |
$47.51 |
$4,765,250 |
D/D |
(100,000) |
505,069 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-07-15 |
4 |
AS |
$57.33 |
$5,160,132 |
D/D |
(90,000) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-08-14 |
4 |
AS |
$58.71 |
$5,288,881 |
D/D |
(90,000) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
S |
$33.10 |
$5,513,043 |
D/D |
(166,296) |
448,182 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-05-17 |
4 |
S |
$55.55 |
$5,562,700 |
D/D |
(100,000) |
518,581 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-10-14 |
4 |
AS |
$62.39 |
$5,628,187 |
D/D |
(90,000) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-09-16 |
4 |
AS |
$63.05 |
$5,679,962 |
D/D |
(90,000) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-04-14 |
4 |
AS |
$66.47 |
$6,032,482 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-11-14 |
4 |
AS |
$68.86 |
$6,197,292 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
S |
$35.00 |
$6,335,590 |
D/D |
(180,000) |
415,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-12-16 |
4 |
AS |
$71.75 |
$6,457,941 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-25 |
4 |
S |
$68.01 |
$6,467,698 |
D/D |
(95,000) |
519,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-01-14 |
4 |
AS |
$73.60 |
$6,681,147 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-07 |
4 |
S |
$45.10 |
$6,765,330 |
D/D |
(150,000) |
1,076,525 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-14 |
4 |
AS |
$75.36 |
$6,829,705 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-01-15 |
4 |
AS |
$97.81 |
$6,893,083 |
D/D |
(70,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-10-15 |
4 |
AS |
$98.02 |
$7,003,220 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-03-16 |
4 |
AS |
$100.36 |
$7,056,206 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-02-08 |
4 |
S |
$44.40 |
$7,063,189 |
D/D |
(158,820) |
1,062,733 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-05-06 |
4 |
S |
$38.40 |
$7,166,914 |
D/D |
(186,504) |
477,150 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-12-15 |
4 |
AS |
$102.22 |
$7,168,741 |
D/D |
(70,000) |
127,936 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-11-16 |
4 |
AS |
$102.26 |
$7,185,419 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
AS |
$102.65 |
$7,210,740 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
193 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
